The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of the BIMES trial, a phase II single arm study assessing efficacy and safety of bintrafusp alfa in previously treated advanced malignant pleural mesothelioma (GECP 20/09).
 
Ernest Nadal
Honoraria - Apollomics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck Serono; MSD; Pfizer; Pierre Fabre; Qiagen; Roche; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; MSD; Pfizer; Roche
 
Paloma Martín-Martorell
No Relationships to Disclose
 
Jose Carlos Benítez
No Relationships to Disclose
 
Maria Angeles Sala
No Relationships to Disclose
 
Susana Cedres Perez
Consulting or Advisory Role - Amphera; Bristol-Myers Squibb; MSD Oncology
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech; Roche/Genentech
 
Carlos Álvarez Fernandez
No Relationships to Disclose
 
Manuel Domine
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Pfizer; Roche; Takeda
 
Elia Sais
No Relationships to Disclose
 
Maria Saigi
No Relationships to Disclose
 
Rafael Lopez Castro
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Roche; Takeda
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; MSD Oncology; Novartis; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD; Novartis; Roche; Takeda
 
Laia Vilà
Honoraria - AstraZeneca Spain; Pfizer; Roche; Sanofi/Regeneron
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Takeda
 
Bartomeu Massuti
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen; Merck Serono; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche; Sanofi/Regeneron
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; MSD Oncology; Roche
 
Rosario Garcia Campelo
No Relationships to Disclose
 
Mariano Provencio
Honoraria - AstraZeneca; BMS; Janssen; Lilly; MSD; Pfizer; Roche; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Lilly; Merck; MSD; Pfizer; Roche; Roche; Takeda
Speakers' Bureau - AstraZeneca; BMS; MSD; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD; Pfizer; Pierre Fabre (Inst); Roche (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca; BMS; Boehringer Ingelheim; Bristol Myers Squibb Company; Lilly; MSD; Pierre Fabre; ROCHE; Roche; Takeda
Other Relationship - Pfizer
 
Begona Campos
No Relationships to Disclose